conclusions aaSI and PP are higher in microalbuminuric T1DM patients compared to healthy controls. The nocturnal BP reduction and systolic daytime BP variability are determinants of aaSI. We propose these associations to reflect biological characteristics of arterial stiffness.
Recently, ambulatory arterial stiffness index (AASI) has been proposed as an indirect measure of arterial stiffness that can be calculated from ambulatory blood pressure (BP) monitoring. Based on the dynamic relationship between diastolic and systolic BP over 24 h, AASI is defined as 1 minus the regression slope of diastolic on systolic BP during ambulatory monitoring. 1,2 AASI correlates with validated direct measures for arterial stiffness. 3 Furthermore, AASI predicts cardiovascular mortality especially stroke in nondiabetic normo-and hypertensive patients even after adjustment for traditional risk factors including mean arterial pressure and pulse pressure (PP). [4] [5] [6] [7] [8] AASI has also been associated to the metabolic syndrome. 9 In cross-sectional studies of middle-aged untreated hypertensive patients, AASI was found to be associated with microalbuminuria after adjustment for 24-h systolic BP. 10, 11 A follow-up study of type 2 diabetes mellitus patients found AASI to predict progression of microalbuminuria, however not independently when controlling for PP. 12 Microalbuminuria is a powerful independent predictor of arterial complications in type 1 diabetes mellitus (T1DM). [13] [14] [15] In T1DM patients, microalbuminuria has been found to be associated with arterial stiffness, as estimated by ultrasonography. 16, 17 However, ultrasonographic methods are time consuming and require special equipment and trained observers. To our knowledge, AASI has not been investigated in microalbuminuric T1DM patients.
AASI has recently been associated to nocturnal BP fall and PP 18, 19 as well as variability in BP. 20, 21 Nocturnal BP fall and PP are linked to micro-and macrovascular complications [22] [23] [24] and arterial stiffness. Variability in BP expressed as s.d. has been associated to markers of arterial stiffness 25 and macrovascular complications; 26 however, the latter association was not significant after adjusting for confounders.
The significance of the association of AASI to BP variation (BP variability and nocturnal BP fall) 18, 20, 27, 28 and the interpretation and validity of AASI as a marker of arterial stiffness has generated an ongoing debate. 19, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] Background ambulatory arterial stiffness index (aaSI) has been proposed as an indirect measure of arterial stiffness. The aims of this study were (i) to analyze aaSI and pulse pressure (PP) in micro-and normoalbuminuric type 1 diabetes mellitus (T1DM) patients and healthy controls and (ii) to explore the relation between nocturnal blood pressure (BP) reduction, BP variability, and aaSI.
Methods ambulatory BP monitoring was performed in 34 micro-and 34 normoalbuminuric T1DM patients matched for gender, age, and diabetes duration and in 34 nondiabetic controls matched for gender and age. aaSI and PP were calculated based on 24-h, day, and night BP recordings. results aaSI increased from the control group (0.30 ± 0.14) to the normo-(0.35 ± 0.15) and microalbuminuric group (0.41 ± 0.19; P < 0.05).
after adjustment for nightly systolic BP reduction and systolic daytime BP variability (s.d.) in multivariate analysis, the association weakened and became nonsignificant (P = 0.078). No significant intergroup differences were found when aaSI was calculated separately from day and night BP data. There was no significant difference between day and night aaSI. The 24-h PP increased from the control group (48 ± 7 mm Hg) to the normo-(50 ± 6 mm Hg) and microalbuminuric group (54 ± 9 mm Hg; P < 0.01). The association remained in the multivariate analysis. Day and night PPs were higher in microalbuminuric patients compared to healthy controls.
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AASI and PP in Microalbuminuric Type 1 Diabetic Patients
The aims of this study were (i) to analyze AASI and PP in micro-and normoalbuminuric T1DM patients and healthy controls and to investigate determinants of AASI, thus (ii) to explore the relation between nocturnal BP reduction, BP variability (expressed as s.d.), and AASI.
Methods
Type 1 diabetic subjects with normo-(n = 34) and microalbuminuria (n = 34) were matched for diabetes duration, age, and gender and with nondiabetic controls (n = 34) for age and gender as previously described. 40 Patients were recruited from outpatient centers in Aarhus county. Inclusion criteria for patients were age <50 years and type 1 diabetes which was defined as a constant need for insulin treatment since diagnosis before the age of 35 years. No patients were included if they had previous or present treatment with antihypertensive drugs or diuretics. Controls were recruited among medical students and friends of the patients and individually matched to their diabetic counterpart for sex and age.
All subjects had 24-h ambulatory BP monitored using SpaceLabs model 90202 (SpaceLabs Monitors, Redmond, WA). The monitors were programmed to perform BP measurements every 20 min from 0600 to 2400 hours and every hour from 2400 to 0600 hours. Day and night BP were calculated based on individual diary information on the day and night period.
Patients were designated as having microalbuminuria if urinary albumin excretion was in the range 20-200 µg/min in at least two of three overnight urine samples collected within 1 week.
For the statistical analysis, we used SPSS software version 14.0 (SPSS, Chicago, IL) and SAS version 9.1 (SAS Institute, Cary, NC) (Proc Mixed).
AASI was computed in accordance with methods described by Dolan et al. 1 From 24-h recordings, the regression slope of diastolic on systolic BP was calculated for each participant. The regression line was not forced through zero. AASI was calculated as 1 minus the regression slope.
We tested data for normality by Lilliefors test and first compared the subject-specific 24-h AASI and PP values by oneway analysis of variance (ANOVA) with F-test of equal means. Nightly systolic and diastolic BP reduction were analyzed in turn on the full data set by a two-way ANOVA with repeated measurements modeling the specific means during night and day in each of the three groups. Furthermore, both BP variables were analyzed simultaneously by a similar two-way MANOVA. Differences between groups were assessed by unpaired t-test if ANOVA showed significant differences of means and by χ 2 for trend for the categorical variables smoking status and retinopathy.
In the analysis of day and night AASI values, we used a random coefficient regression model with subject-specific random intercept and slope 41 as the conditions for ANOVA are not fulfilled for this analysis (the subject-specific values can have quite different standard errors on day and night caused by different number of observations on day and night and by subject-specific degree of fit to the linear regression).
In the random coefficient regression model, all data on every subject in all groups are entered at once and the slope and hence AASI value is calculated directly at the group level. The model expands the standard linear multiple regression model to allow for repeated (and hence correlated) observations on each subject. In this model, the subject-specific intercept and slope vary in a random manner around the group level similar to residuals in an ordinary linear regression. The model estimates the group intercept and slope, and not the subject-specific values, but the model does estimate the s.d. of the random variation on these subject-specific values (interindividual variation). Hence the model avoids estimation of individual night AASI values, which otherwise would be based on few observations and consequently greater uncertainty.
Nonparametric measures of association were estimated by Spearman's ρ.
Data are presented as means ± s.d., except (i) day and night AASIs are presented as group-mean ± s.e. as these are estimated in random coefficient regression as described above and (ii) number of observations for calculating day and night AASI and s.d. systolic day and night BP are reported as median (range) as this is statistically more appropriate. A two-tailed P value of <0.05 was considered statistically significant. The study was approved by the local ethical committee and all participants gave their informed consent.
results clinical characteristics
Subjects and groups were well matched with regard to age, sex, body mass index, height, and the diabetic patients for duration of diabetes as previously reported 40 (Table 1) . Controls, normo-, and microalbuminuric subjects differed with regard to 24-h, day and night BP, and smoking status. Normo-and microalbuminuric subjects differed with regard to HbA 1c and retinopathy.
24-h aasi in controls, normo-, and microalbuminuric diabetics
24-h AASI increased significantly from the control group to the normo-and microalbuminuric diabetic groups (P < 0.05 for trend, Figure 1) . The difference between groups was significant in ANOVA (P < 0.05, Table 2 ) and unpaired t-test showed the differences to be significant between the control group and the microalbuminuric group (P < 0.01). The differences between AASI in the three groups (controls, normo-, and microalbuminurics) remained significant after adjusting for the covariates age, sex, height, body mass index, smoking status, and 24-h heart rate in multiple regression (P < 0.001) and AASI in the microalbuminuric group remained significantly higher than in the control group ( Table 3 , adjusted model).
aasi and intergroup differences in BP variations
There was a nonsignificant trend in the nightly systolic BP reduction between the groups, controls > normoalbuminurics > microalbuminurics, and significant differences in the nightly diastolic BP reductions, controls > normoalbuminurics > microalbuminurics ( Table 2) . However, multivariate articles AASI and PP in Microalbuminuric Type 1 Diabetic Patients analysis of the combined nightly systolic and diastolic BP reduction by MANOVA showed no significant intergroup differences (P = 0.086).
BP variability expressed as s.d. showed intergroup differences with significantly higher daytime systolic BP variability in microalbuminuric patients compared to both patients with normoalbuminuria (P < 0.05) and controls (P < 0.01) ( Table 2) . No differences were found for night time systolic BP variation ( Table 2 ) or daytime and night time diastolic BP variations (data not shown).
The differences between AASI in the three groups (controls and normo-and microalbuminurics) became nonsignificant in multiple regression after additional simultaneous adjustment for the covariates nightly systolic BP reduction and daytime systolic BP variation (s.d.) (P = 0.076) ( Table 3 , fully adjusted model). Adjustment for only nightly systolic BP reduction or systolic daytime variability did not abolish the significant difference between AASI in the three groups (P < 0.05 and P < 0.01, respectively), data not shown.
day and night aasi
To further explore the effect of BP variation, we estimated day and night AASI for the three groups based on day and night BP data in random coefficient regression. Day and night AASIs in each group were calculated based on 47 (37-60) (mean (range)) day and 12 (6-24) night observations from each subject.
In contrast to analysis on 24-h data, there were no significant intergroup differences in day AASI or night AASI (P = 0.57 and P = 0.48, respectively) ( Table 2 ). Hence the model could be reduced to a simpler model with two regression lines common for all three groups, one for day and one for night. Further analysis in this model showed no statistically significant difference between the day and night regression coefficients (slopes) and thus day and night AASI (P = 0.35). As illustrated in the schematic Figure 2 , there was only one common regression coefficient for day and night BP for all three groups in the final 
PP in controls, normo-, and microalbuminuric diabetics
As indicated in Table 2 , 24-h and day PP were significantly higher in microalbuminuric patients than in normoalbuminuric patients (P < 0.05 for both) and controls (P < 0.01 for both), whereas the difference in night PP was only statistically significant between microalbuminuric patients and controls (P < 0.01). After adjusting for relevant covariates (age, sex, height, body mass index, smoking status, and heart rate) in multiple regression, the association remained statistically significant for 24-h PP (P < 0.001), and PP in both the microalbuminuric and the normoalbuminuric groups remained significantly higher than in the control group ( Table 4) . The association also remained for day PP (P < 0.001) and night PP (P < 0.001), data not shown.
discussion
Our main finding was that AASI calculated from 24-h data is significantly higher in T1DM patients with microalbuminuria compared to healthy controls. Second, AASI was closely associated to both diurnal BP variation and BP variability. When nightly reduction in systolic BP and systolic daytime BP variability (expressed as s.d.) was included in the multivariate analysis, the differences in 24-h AASI between groups were no longer significant ( Table 4 ). The association of AASI to BP variation was further explored in the calculation of day and night AASI. AASI appeared identical in controls, normo-, and microalbuminuric patients, calculated on day and night data separately. The association of 24 h, day and night AASI, and BP variation is outlined in the schematic Figure 2 . It illustrates the nightly BP reduction as an important driving force for 24-h AASI and offers an explanation for the seeming paradox with identical slopes (and hence AASI) when analyzing day and night data separately but a steeper slope (corresponding to a lower AASI) when pooling night and day observations. The absolute nocturnal BP reduction affects 24-h AASI via the different spatial locations of the clusters of diastolic and systolic observations for day-and night time: the more pronounced the nocturnal diastolic BP reduction, the greater the vertical distance between the day-and night clusters of observations, and thus the steeper the 24-h regression line. On the other hand, the more marked the nocturnal systolic BP reduction, the greater the horizontal distance between clusters of day and night observations and thus the flatter the 24-h regression line. Thus the combined effect of the systolic and diastolic nightly BP reduction is important in determining the slope of the 24-h regression line. Based on the results from the random coefficient regression analysis which showed significant differences in 24-h ambulatory arterial stiffness index (aaSI) (P < 0.05), but no significant intergroup differences in day aaSI or night aaSI (P = 0.57 and P = 0.48, respectively). There was no significant difference between day and night aaSI (P = 0. We found a nonsignificant trend in the nightly systolic BP reduction controls > normoalbuminurics > microalbuminurics ( Table 2 ) and significant differences in the nightly diastolic BP reductions, controls > normoalbuminurics > microalbuminurics. Thus, these dynamics are part of the explanation for the differences in slope (and hence AASI) between the groups. However, multivariate analysis of the combined effect of the differences between the groups in the absolute diastolic and systolic nocturnal BP reduction did not reach the level of statistic significance, implying that the intergroup differences in AASI in this data set were also explained by intergroup differences in systolic daytime variability: when performing regression analysis on 24-h data, the observed greater variation in systolic daytime BP in microalbuminuric subjects (as illustrated schematically with an elongated ellipse in Figure 2) resulted in a flatter regression slope and thus higher AASI due to the principle of minimizing the sum of squared errors in the regression analysis.
Hence, we have demonstrated that the reduction of BP at night is an important driving force for the slope of the 24-h regression line. In this study, it explained why the 24-h regression lines were steeper than day and night regression lines when both data sets were combined and thus why 24-h AASI values in all groups were lower than day and night AASI. In addition, the nightly BP reduction in combination with intergroup variability in systolic daytime BP resulted in intergroup differences when performing regression analysis on 24-h data. After adjustment for these variables in multiple regression, the differences in AASI weakened and became nonsignificant ( Table 3) .
Although the demonstrated relation between 24-h AASI and day and night AASI is methodologically interesting, we stress that the concept of AASI and documented prognostic significance is related to the dynamic relation between systolic and diastolic BP as modulated throughout 24 h.
AASI has been previously associated to nocturnal BP fall 18, 19, 28 and a high day AASI compared to 24-h AASI has been reported. 37 Schillaci and co-workers have investigated the association between the night/day ratio of BP and AASI, and reported that an increasing nocturnal drop in BP is associated with a steeper slope of the regression line (and lower AASI), hence nondippers had a higher AASI than dippers. 18 Our findings have extended and nuanced this observation by illustrating that it is the combined effect of the systolic and diastolic BP reduction that determines the actual slope of the 24-h regression line (and thus AASI).
In the study by Schillaci and co-workers, the relation between AASI and aortic pulse wave velocity disappeared when 18 Other studies found a significant correlation between PP and AASI 28 or adjusted for PP and/or mean arterial pressure [4] [5] [6] 12 in multiple regression analysis. However, in regression modeling it might be considered conceptually inappropriate to enter a variable that is derived from the response variable as an explaining variable (the response variable cannot be on both sides of the regression equation) as this induces spurious correlations. Thus, variables derived from the diastolic BP like PP or mean arterial pressure cannot be used as explaining variables in the regression analysis with AASI as the dependent variable. Similarly, no adjustment was made for AASI, systolic night reduction or systolic BP variability in the regression analysis with PP as the explaining variable.
We did not adjust for 24-h systolic BP in our regression analysis as it is conceptually inappropriate to adjust for a common determinant (confounder) of both albuminuric status and arterial stiffness.
BP variability, especially night time systolic BP variability, has been associated with direct measures of arterial stiffness. 25 We extended this observation with the finding of an association between day systolic BP variability and AASI, suggesting AASI as an indirect measure of arterial stiffness. A possible common underlying pathophysiological link between AASI, nocturnal BP reduction, and BP variability could be autonomic dysfunction, which per se is associated with diminished nocturnal BP reduction. So far no study has examined the relation between autonomic function and AASI.
Recently, calculation of AASI based on symmetric regression (s-AASI) has been proposed as a method to reduce the dependence of AASI on BP variation, especially the nightly BP reduction 20 and has been associated to all-cause mortality. 21 The method has, however, not been compared with direct measures of arterial stiffness.
Another novel finding was increased PP in microalbuminuric patients with type 1 diabetes. This is in accordance with findings in type 2 diabetic patients. 22 In type 2 diabetes mellitus subjects, PP has been found to predict progression to microalbuminuria better than AASI. 12 Limitations of the study: the cross-sectional nature of this study does not allow for conclusions regarding causality with respect to autonomic dysfunction, BP variability, PP, AASI, and progression to microalbuminuria. No longitudinal study has, to our knowledge, compared PP vs. AASI as predictors of progression to microalbuminuria in T1DM subjects. AASI and PP were not compared to a direct measure of arterial stiffness such as aortic pulse wave velocity and were not associated to direct measures for autonomic dysfunction. The study population is young and thus the results should be confirmed in an older cohort. The night time BP was measured at relatively large intervals with relatively fewer observations. Thus individual night time estimates are less precise than the daytime estimates. However, to account for this we estimated day and night AASI in the random coefficient model, where estimates are computed only at the group level and thus more precise.
In conclusion, since both AASI and PP were higher in microalbuminuric T1DM patients compared to healthy controls, we propose that the changes in AASI reflect underlying biological characteristics of arterial stiffness. AASI is closely associated to diurnal BP variation and BP variability and it can be hypothesized that a possible underlying pathophysiological mechanism is autonomic dysfunction. Further studies are required to examine this and whether the measurement of AASI in diabetic subjects can identify patients with early and subclinical macrovascular disease.
We have added additional knowledge to the study of AASI in demonstrating that nocturnal BP reductions and systolic daytime BP variability are important parameters in determining AASI.
